inhibitor

(redirected from Carbonic anhydrase inhibitor)
Also found in: Dictionary, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to Carbonic anhydrase inhibitor: acetazolamide
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Antonyms for inhibitor

a substance that retards or stops an activity

References in periodicals archive ?
The most widely prescribed glaucoma drugs include the prostaglandin analogs (PGAs) that lower IOP by increasing the aqueous drainage through the unconventional uveoscleral outflow pathway, whereas the non-PGA drug classes such as the beta blockers, alpha agonists, and carbonic anhydrase inhibitors, lower IOP by decreasing the production of aqueous humor.
Sexual dysfunction and anorgasmia are rarely observed due to carbonic anhydrase inhibitors (5,7,8).
Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression.
The effect of luminal exposure to acetazolamide, a carbonic anhydrase inhibitor, on Isc was sporadic, and produced only a 16% overall reduction of Isc.
Ophthalmologic advice should be sought and alternative treatment, with a topical sympathomimetic or carbonic anhydrase inhibitor, used while waiting for review by the eye surgeons.
In the treatment of PCH, strategies include drugs such as, indomethacin, carbonic anhydrase inhibitors and procedures that may lower intracranial pressure.
Acetazolamide, a carbonic anhydrase inhibitor, has been used in the adjunctive treatment of open-angle glaucoma and epilepsy.
14) Other combination medications are available in a single bottle, such as Cosopt, which contains the beta-blocker timolol and a carbonic anhydrase inhibitor (dorzolamide).
The new ophthalmic suspension is a fixed-dose combination of a carbonic anhydrase inhibitor (Brinzolamide 1.
a) Topical prostaglandin analogue b) Topical beta-blocker c) Topical carbonic anhydrase inhibitor d) Laser trabeculoplasty
Sales of TRUSOPT, the first carbonic anhydrase inhibitor made in a topical (eyedrop) formulation, have continued to grow due to its introduction in several new markets, making it one of the most widely prescribed anti-glaucoma medicines in the world.
Sales of TRUSOPT, the first carbonic anhydrase inhibitor made in a topical (eyedrop) formulation, have continued to grow since it was first introduced, making it one of the most widely prescribed anti-glaucoma medicines in the world.
Sales of TRUSOPT, the first carbonic anhydrase inhibitor made in a topical (eyedrop) formulation, have proceeded at a strong pace since it was first introduced in the United States in May 1995.
Sales of TRUSOPT (R), the first carbonic anhydrase inhibitor made in a topical (eyedrop) formulation, have proceeded at a strong pace since it was first introduced in the United States in May 1995.
Full browser ?